Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1956 Jul 15;75(2):98–100.

Mestinon (Pyridostigmine Bromide) in Myasthenia Gravis*

Herbert Schwarz
PMCID: PMC1824124  PMID: 13343058

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUER H., SCHMID O. Zur medikamentösen Behandlung der Myasthenie. Dtsch Z Nervenheilkd. 1953;169(6):427–437. [PubMed] [Google Scholar]
  2. CASIER H., VERBEKE R. Parasympathomimetic symptoms, sensitivity to acetylcholine and decurarization, in relation to inhibition of cholinesterases. Arch Int Pharmacodyn Ther. 1950 Aug 1;83(3):452–463. [PubMed] [Google Scholar]
  3. TETHER J. E. Treatment of myasthenia gravis with mestinon bromide. J Am Med Assoc. 1956 Jan 21;160(3):156–158. doi: 10.1001/jama.1956.02960380004002. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES